DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 115 filers reported holding DENALI THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $186,000 | -13.5% | 3,669 | +33.6% | 0.01% | 0.0% |
| Q2 2021 | $215,000 | +54.7% | 2,747 | +12.5% | 0.01% | +42.9% |
| Q1 2021 | $139,000 | +58.0% | 2,441 | +0.6% | 0.01% | +16.7% |
| Q3 2020 | $88,000 | +576.9% | 2,426 | +420.6% | 0.01% | +500.0% |
| Q2 2020 | $13,000 | -50.0% | 466 | -69.2% | 0.00% | -50.0% |
| Q1 2020 | $26,000 | +271.4% | 1,513 | +375.8% | 0.00% | +100.0% |
| Q4 2018 | $7,000 | -22.2% | 318 | -19.9% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | – | 397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |